The pathogenesis of ME/CFS, a disease characterized by fatigue, cognitive dysfunction, sleep disturbances, orthostatic intolerance, fever, irritable bowel syndrome (IBS), and lymphadenopathy, is poorly understood. We report biomarker discovery and topological analysis of plasma metabolomic, fecal bacterial metagenomic, and clinical data from 50 ME/CFS patients and 50 healthy controls. We confirm reports of altered plasma levels of choline, carnitine and complex lipid metabolites and demonstrate that patients with ME/CFS and IBS have increased plasma levels of ceramide. Integration of fecal metagenomic and plasma metabolomic data resulted in a stronger predictive model of ME/CFS (cross-validated AUC = 0.836) than either metagenomic (cross-validated AUC = 0.745) or metabolomic (cross-validated AUC = 0.820) analysis alone. Our findings may provide insights into the pathogenesis of ME/CFS and its subtypes and suggest pathways for the development of diagnostic and therapeutic strategies.
Insights into M.E: The pathogenesis of ME... - Ramsays Disease
Insights into M.E

Written by

Ian123
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
More evidence something out of whack just no smoking gun on cause
Not what you're looking for?
You may also like...
Research into CFS/M.E : Sleep study -London
http://www1.imperial.ac.uk/departmentofmedicine/divisions/brainsciences/psychopharmacology/saffe/...
A young girl with severe M.E
Hi everyone I'm looking for help on behalf of someone
I've been chatting to a mother in my local...
UK CFS/M.E. Research Collaborative 2
Second day sound quality poor in parts
https://www.youtube.com/watch?v=6sTXIgV0tTM...